Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Sanfilippo Syndrome

Metabolic & Lysosomal

Sanfilippo Syndrome Clinical Trials and Treatments

Also called MPS III, Mucopolysaccharidosis Type III, Mucopolysaccharidosis III, Sanfilippo Disease, MPS IIIA, Sanfilippo Syndrome Type A, MPS IIIB, Sanfilippo Syndrome Type B

Sanfilippo syndrome is the name families and clinicians use for mucopolysaccharidosis type III. It comes in four subtypes, A through D, each caused by the loss of a different enzyme in the chain that breaks down heparan sulfate: heparan sulfamidase in type A, alpha-N-acetylglucosaminidase in type B, acetyl-CoA alpha-glucosaminide N-acetyltransferase in type C, and N-acetylglucosamine-6-sulfatase in type D.

In plain words, Sanfilippo syndrome happens when the body cannot break down a sugar chain called heparan sulfate, so it builds up inside cells. Most of the harm is to the brain in childhood, leading to behavior changes and then loss of speech, thinking and movement.

Get an email when new Sanfilippo Syndrome trials open or the FDA decides. Get alerts

Sanfilippo Syndrome

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 5 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines1

Fayuvi

Sanfilippo Syndrome has 1 FDA-approved medicine, 9 open or active clinical trials (5 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for Sanfilippo Syndrome

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Sanfilippo Syndrome

Whichever enzyme is missing, the result is the same: heparan sulfate accumulates inside cells, above all in the brain, where partially broken-down fragments are toxic to nerve cells and set off inflammation and cell death.

Keep reading about Sanfilippo Syndrome

What makes Sanfilippo different from the other MPS disorders is where it strikes. The physical signs that mark Hurler or Hunter syndrome are mild here, limited to slightly coarse features, an enlarged liver and spleen, and some skeletal changes. The brain takes the full weight of the disease.

Children appear healthy at birth and through infancy, and the first signs, usually between ages 2 and 6, look like a behavioral or developmental problem: hyperactivity, a plateau in development, delayed speech. What follows is a relentless childhood dementia. Words already learned disappear, skills already mastered unwind, and behavior deteriorates into severe intellectual disability.

Movement goes next, with loss of coordination, an unsteady gait and eventually the inability to walk. Sleep disturbance is common and severe, particularly in type A, and seizures develop in about 3 of every 4 children in the later stages. Type A progresses fastest and type C somewhat slower, but every form leads to profound disability.

What are the symptoms of Sanfilippo Syndrome?

These are common symptoms of Sanfilippo Syndrome, and how strong they are varies from person to person.

  • Behavioral problems and psychiatric symptoms starting in childhood
  • Progressive intellectual disability and cognitive decline
  • Loss of speech and language abilities
  • Progressive motor deterioration and movement disorders
  • Sleep disturbances and hyperactivity
  • Seizures in later stages

Who gets Sanfilippo Syndrome?

Sanfilippo syndrome typically shows itself between ages 2 and 6, usually as behavioral change or a stall in development, with progressive neurological decline following. There are 4 genetic subtypes, A through D, with different rates of progression; type A is the most common and the fastest. It affects boys and girls equally and is inherited in an autosomal recessive pattern, meaning both parents carry a copy without symptoms. It is most frequent in Scandinavian and Aboriginal Australian populations.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for Sanfilippo Syndrome?

There is currently 1 FDA-approved medication for Sanfilippo Syndrome.

Just prescribed one of these?Your first 90 days, step by stepWhat happens before the first fill, the tests and refills to expect, and help paying, with a one-page handout to print.
rebisufligene etisparvovec
Your first 90 days
Ultragenyx
Search

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Sanfilippo Syndrome treatment

Charity funds and drugmaker programs for Sanfilippo Syndrome, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Charity funds
  • From a charity · TotalAssist (formerly PAN Foundation)
    Mucopolysaccharidosis Type III (Sanfilippo) fund
    Open

    Pays for: Out-of-pocket costs for approved medications, up to $2,500 per year. Requires health insurance (any kind).

  • From a charity · National MPS Society
    Family Assistance Program fund
    Apply directly

    Pays for: Specialized equipment and medical aids not covered by insurance (requires insurance denial and 10% family copay), up to $3,000 per year.

    The foundation says: “Status not shown on page”
  • From a charity · National MPS Society
    Medical Travel Assistance Program fund
    Apply directly

    Pays for: Travel to out-of-town medical appointments more than 125 miles away (per year), up to $550 per year.

    The foundation says: “Status not shown on page”
  • From a charity · National MPS Society
    Journey Assistance Program fund
    Apply directly

    Pays for: Items that ease daily life (40% of purchase price), up to $500 per year.

    The foundation says: “Status not shown on page”
Status as each foundation showed it on October 26, 2026.
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Every program and fund for Sanfilippo Syndrome, by insurance →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Sanfilippo Syndrome

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Sanfilippo Syndrome resources

Reputable organizations and medical references for learning more about Sanfilippo Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Sanfilippo Syndrome

Use this Sanfilippo Syndrome clinical trial finder to see the 5 studies recruiting patients and 4 not yet recruiting in the United States and worldwide, with eligibility criteria in plain English. Of these, 4 test a treatment and 5 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

9 active trials worldwide
Filter:
Sort:
Not yet recruitingObservational study, no treatment givenRecently updatedNCT07855562

MPS IIIA Disease Monitoring Program

Intervention: No Intervention

Sponsor: Ultragenyx Pharmaceutical Inc

The main objective of this observational study is to evaluate the long-term safety and effectiveness of rebisufligene etisparvovec for 10 years after rebisufligene etisparvovec administration.

Ages not specified
Expected to start Nov 2026Updated 1 month agoEst. Oct 2038 (~11y 11m)
RecruitingTreatment trialPhase 2/3Recently updatedNCT02716246

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Intervention: UX111, Prophylactic Immunomodulatory (IM) Therapy, Optimized Prophylactic IM Therapy, Adjuvant IM Therapy

Sponsor: Ultragenyx Pharmaceutical Inc · Abeona Therapeutics, Inc

The main objective of this study is to evaluate the efficacy and safety of UX111 for the treatment of MPS IIIA.

Ages not specified2 locations
Started Apr 2016Updated 1 month agoEst. Mar 2029 (~2y 4m)
Not yet recruitingTreatment trialPhase 3Recently updatedNCT07579910

Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)

Intervention: Tralesinidase alfa (TA)

Sponsor: Spruce Biosciences

The primary objectives of this study are to evaluate the effects of Tralesinidase Alfa (TA) on cognition

Ages 1 Year to 5 Years
Expected to start Dec 2026Updated 1 month agoEst. Aug 2033 (~6y 9m)
RecruitingTreatment trialPhase 2/3Recently updatedNCT06333041

Study of Cannabidiol in Sanfilippo Syndrome

Intervention: Epidiolex, Placebo

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

The goal of this clinical trial is to test cannabidiol in Sanfilippo syndrome. The main questions it aims to answer are: 1) determine the safety of cannabidiol in Sanfilippo syndrome, and 2) explore the efficacy of cannabidiol in treating the neurobehavioral symptoms and functional outcomes of Sanfilippo syndrome.

Ages 4 Years+1 location
Started Apr 2026Updated 1 month agoEst. Apr 2027 (~5 months)
Not yet recruitingTreatment trialPhase 1/2Recently updatedNCT07818759

Single Injection of rAAV9-CMV-hNAGLUop Gene for Patients With Mucopolysaccharidosis (MPS) IIIB

Intervention: rAAV9-CMV-hNAGLUop

Sponsor: NeuroGT

The goal of this clinical trial is to learn if one infusion of rAAV9-CMV-hNAGLUop can treat patients with Sanfilippo syndrome (MPS III) 6 months or older. The main questions it aims to answer are:

* Is the treatment safe?

* Is there a change in enzyme activities,?

Ages 6 Months+1 location
Expected to start Jan 2027Updated 2 months agoEst. Dec 2028 (~2y 1m)
Find Sanfilippo Syndrome trials near you, ranked by distance →
Active trial locations5 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Phase 1
Phase 2
Phase 3
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Sanfilippo Syndrome trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Sanfilippo Syndrome foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Sanfilippo Syndrome patient communities

Facebook groups, Reddit communities and YouTube channels where Sanfilippo Syndrome patients, caregivers and advocacy groups talk.

Sanfilippo Syndrome news and guides

Trial Friend articles about Sanfilippo Syndrome, newest first

Companies developing Sanfilippo Syndrome treatments

Drugmakers that list Sanfilippo Syndrome in their rare disease portfolio, 5 in all.

Questions people ask about Sanfilippo Syndrome